Active Ingredient(s):Cenobamate FDA Approved: * November 21, 2019 Pharm Company: *SK LIFE SCIENCE INC Category:Anticonvulsant
Cenobamate, sold under the brand names Xcopri (US) and Ontozry (EU), is a medication used for the treatment of partial-onset seizures, a kind of epilepsy, in adults. It is taken by mouth.
Cenobamate was approved for medical use in the United States in November 2019 and placed in Schedule V of the Controlled Substances Act in March 2020. Cenoba...
* May have multiple approval dates, manufacturers, or labelers.